Citigroup Inc Rani Therapeutics Holdings, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$8.23 - $12.4 $674 - $1,016	-82 Reduced 21.75%	295 $3,000
Q2 2022 Aug 10, 2022	SELL	$8.0 - $14.25 $360 - $641	-45 Reduced 10.66%	377 $4,000
Q1 2022 May 12, 2022	SELL	$12.21 - $23.14 $5,396 - $10,227	-442 Reduced 51.16%	422 $6,000
Q4 2021 Feb 10, 2022	BUY	$16.09 - $35.0 $13,901 - $30,240	864 New	864 $14,000

5.8M

2.5K

2.2K

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $32.8M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.